MedPath

Vasopressin

Generic Name
Vasopressin
Brand Names
Vasostrict
Drug Type
Small Molecule
Chemical Formula
C92H130N28O24S4
CAS Number
11000-17-2
Unique Ingredient Identifier
Y87Y826H08

Overview

Vasopressin (arginine-vasopressin or antidiuretic hormone) is a nonapeptide primarily produced in the hypothalamus that exhibits diverse physiological functions related to diuresis, hemodynamic modulation, and behaviour. Vasopressin is very similar to oxytocin, differing in the third and eighth amino acids. Despite a wide variety of functions, exogenous vasopressin is primarily used to control blood pressure during systemic shock by increasing vasoconstriction and renal fluid reuptake by acting through V and V cellular receptors. The vasopressive effect of posterior pituitary gland extracts was noted in 1895, while vasopressin itself was not purified until 1951. It has been used for more than five decades for varying conditions, including variceal bleeding, diabetes insipidus, and, more recently, vasodilatory shock. It is currently marketed under the trademark VASOSTRICT® by PAR Pharmaceuticals.

Background

Vasopressin (arginine-vasopressin or antidiuretic hormone) is a nonapeptide primarily produced in the hypothalamus that exhibits diverse physiological functions related to diuresis, hemodynamic modulation, and behaviour. Vasopressin is very similar to oxytocin, differing in the third and eighth amino acids. Despite a wide variety of functions, exogenous vasopressin is primarily used to control blood pressure during systemic shock by increasing vasoconstriction and renal fluid reuptake by acting through V and V cellular receptors. The vasopressive effect of posterior pituitary gland extracts was noted in 1895, while vasopressin itself was not purified until 1951. It has been used for more than five decades for varying conditions, including variceal bleeding, diabetes insipidus, and, more recently, vasodilatory shock. It is currently marketed under the trademark VASOSTRICT® by PAR Pharmaceuticals.

Indication

1.诊断和治疗由于缺乏抗利尿激素而引起的尿崩症,也用于其他药物效果不佳的腹部肌肉松弛; 2.脑外科手术后或头颅创伤后多尿的初期治疗; 3.用于食管、胃肠道消化道疾病的急性大出血的辅助治疗。

Associated Conditions

  • Acute Circulatory Failure

FDA Approved Products

Vasopressin
Manufacturer:American Regent, Inc.
Route:INTRAVENOUS
Strength:20 [USP'U] in 1 mL
Approved: 2023/01/01
NDC:0517-1030
VASOPRESSIN
Manufacturer:Fresenius Kabi USA, LLC
Route:INTRAVENOUS
Strength:20 [USP'U] in 1 mL
Approved: 2022/07/01
NDC:65219-039
Vasostrict
Manufacturer:Par Pharmaceutical, Inc.
Route:INTRAVENOUS
Strength:1 [USP'U] in 1 mL
Approved: 2023/11/16
NDC:42023-268
vasopressin
Manufacturer:Amneal Pharmaceuticals LLC
Route:INTRAVENOUS
Strength:20 [USP'U] in 1 mL
Approved: 2023/05/11
NDC:70121-1642
Vasostrict
Manufacturer:Medical Purchasin Solutions, LLC
Route:INTRAVENOUS
Strength:20 [USP'U] in 1 mL
Approved: 2023/06/01
NDC:71872-7014

Singapore Approved Products

VASOPRESSIN INJECTION USP 20 u/ml
Manufacturer:Fresenius Kabi USA, LLC
Form:INJECTION
Strength:20 u/ml
Online:Yes
Approved: 1995/09/19
Approval:SIN08350P

Drug Development Updates

Stay informed with timely notifications on clinical trials and research advancements.

© Copyright 2025. All Rights Reserved by MedPath